4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-021052
Chief Financial Officer acquired 2,500 shares (grant or award)
- Chief Financial Officer gave up 1,033 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2019-03-22 | Grant or award | +2,500 | $5.98 | $14,950 | 20,954 | D |
| Bonner Michael Chief Financial Officer | 2019-03-22 | Shares withheld for taxes | +1,033 | $5.62 | $5,805 | 19,921 | D |
Loading xslF345X03/doc4.xml…